Green Spring Technology

Shenzhen Green Spring Technology is a prominent in vitro diagnostics (IVD) company based in China, specializing in the research, development, and manufacturing of rapid testing solutions. The company rose to international prominence during the COVID-19 pandemic as a leading provider of high-quality SARS-CoV-2 antigen rapid test kits, which received extensive validation from various European health authorities. Their product portfolio extends beyond COVID-19 to include diagnostic assays for influenza, respiratory syncytial virus (RSV), and other infectious diseases. Green Spring Technology utilizes a robust lateral flow immunoassay platform to deliver point-of-care results with high accuracy and ease of use. The company maintains large-scale manufacturing capabilities that comply with international quality management standards, including ISO 13485. Their products are distributed globally, serving both professional healthcare settings and the consumer retail market.